武振宇

主要研究方向为包括高维组学数据分析方法研究、新药临床试验、肿瘤学、医学伦理学等。

主讲卫生统计学、卫生统计学实践等门本科生和研究生课程。

近年来以第一作者或通讯作者发表SCI、国内核心期刊学术论文20余篇，累积影响因子100分以上。

担任《临床肝胆病杂志》统计方法特聘审稿专家；CSCO生物统计学专家委员会委员，中华预防医学会健康保险专业委员会分会委员，中华预防医学会生物统计分会青年委员。

1. Xu H, Zhang F, Xu W, Li J, Zhu J, Zhang M, Wu Z ^#, Qin G. Annual glycemic variations and risk of cancer among Chinese patients with type 2 diabetes mellitus: A population-based cohort study in Shanghai. Diabetes Res Clin Pract. 2021 Jan;171:108552. 
2. Jia H, Li Q, Yuan J, Sun X, Wu Z ^#. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis. Oncologist. 2020; 25(4):e644-e650.
3. Li R, Zhang Y, Ma B, Tan K, Lynn HS, Wu Z ^#. Survival analysis of second primary malignancies after cervical cancer using a competing risk model: implications for prevention and surveillance. Ann Transl Med. 2021;9(3):239. 
4. Ma B, Qin G, Zhang Y, Su C ^#, Wu Z ^#. Life-long Follow-Up of second primary lung and extra-pulmonary cancer in lung cancer patients is needed. J Cancer. 2020;11(16):4709-4715. 
5. Li Z, Li S, Liang Y, Pu H, Tu C, Wu Z ^#, You D ^#. Predictive Value of Postoperative Peripheral CD4+ T Cells Percentage in Stage I-III Colorectal Cancer: A Retrospective Multicenter Cohort Study of 1028 Subjects. Cancer Manag Res. 2020;12:5505-5513. 
6. Liang F^#, Wu Z^#, Mo M, et al. Comparison of Treatment Effect from Randomized Controlled Phase II Trials and Subsequent Phase III Trials Using Identical Regimens in the Same Treatment Setting. European Journal of Cancer. 2019;121:19-28.
7. Li J, Wu Z ^#, Zhao N ^#. Individual Patient Data Meta-Analysis from 16 Trials for Safety Factors in Cytokine Release Syndrome After CAR-T Therapy in Patients with Non-Hodgkin Lymphoma (NHL) and Acute Lymphoblastic Leukemia. Advances In Therapy. 2019;36(10):2881-2894.
8. Qian X, Su C, Zhang B, Qin G, Wang H ^#, Wu Z ^#. Changes in distributions of waist circumference, waist-to-hip ratio and waist-to-height ratio over an 18-year period among Chinese adults: a longitudinal study using quantile regression. BMC Public Health. 2019;19(1):700.
9. Zhao W, He Z, Li Y, Jia H, Chen M, Gu X, Liu M, Zhang , Wu Z ^#, Cheng W^#. Nomogram-based parameters to predict overall survival in a real-world advanced cancer population undergoing palliative care. BMC Palliat Care. 2019;18(1):47.
10. Wu Z, Qin G, Zhao N, Jia H, Zheng X. A Statistical Tool for Risk Assessment as Function of Number of Retrieved Lymph Nodes from Rectal Cancer Patients. Colorectal Dis. 2018;20(8):O199-O206.
11. 张悦,武振宇. 第二原发结直肠癌对前列腺癌患者生存情况影响的分析. 中国卫生统计, 2020;37(3):444-447.
12. 武振宇,郑雪莹. 安慰剂对照在临床研究设计教学中的探讨. 中国卫生统计,2017;34(3):526-527.
13. 武振宇, 贾慧珣. 反安慰剂效应在临床试验中的研究. 医学与哲学. 2012; 33(5B):44-46.

国家青年科学基金，基于进化组合支持向量机（EC-SVM）的代谢组学数据分析方法研究，2011.01月至2013.12月，20万元，已结题，主持。

参加985重大专项：985医学统计与医学信息平台建设计划（资助金额：500万）；

国家 “重大新药创制”科技重大专项课题2项（项目编号：2012ZX10001003，2012ZX09303013）。